POInsulet Corporation company profile
$152.48+2.14%Close 13 Nov 2026 · Market value $10.12B
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod platform includes Omnipod 5, Omnipod DASH, and the Classic Omnipod, a tubeless, self-adhesive disposable Pod controlled by a handheld device or a smartphone app. The company also produces pods for Amgen's Neulasta Onpro kit. In the United States, it sells primarily through wholesalers, with additional sales to healthcare organizations, pharmacies, and consumers. Internationally, it sells directly to consumers or through distributors and intermediaries. Manufacturing is conducted at facilities in Acton, Massachusetts, and Johor, Malaysia, with a contract manufacturing facility in China.
A summary of the business section of the company's latest annual report, filed 18 Feb 2026.
Company facts
| Ticker | PODD · Nasdaq |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Equipment |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1145197 |
|---|
| Latest annual report | 10-K, filed 18 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| James Hollingshead | Former President and CEO | 43.1K · < 1% | Shares withheld for tax, 28 Apr 2025 |
|---|
| John Kapples | SVP and General Counsel | 40.5K · < 1% | Shares withheld for tax, 27 Feb 2026 |
|---|
| Eric Benjamin | EVP and COO | 36.1K · < 1% | Shares withheld for tax, 27 Feb 2026 |
|---|
| Timothy J. Scannell | Director | 31.4K · < 1% | Grant or award, 20 May 2026 |
|---|
| Jessica Hopfield | Director | 31.3K · < 1% | Grant or award, 20 May 2026 |
|---|
| Michael R. Minogue | Director | 22.5K · < 1% | Grant or award, 20 May 2026 |
|---|
| Ashley A. McEvoy | President and CEO · Director | 13.6K · < 1% | Open-market purchase, 21 Aug 2026 |
|---|
| Mark Field | SVP & Chief Technology Officer | 7.0K · < 1% | Shares withheld for tax, 28 Feb 2025 |
|---|
| Prem Singh | SVP, Global Operations | 5.8K · < 1% | Shares withheld for tax, 27 Feb 2026 |
|---|
| Elizabeth H. Weatherman | Director | 5.2K · < 1% | Open-market purchase, 3 Jun 2026 |
|---|
| Ana Chadwick | EVP, CFO & Treasurer | 4.6K · < 1% | Shares withheld for tax, 1 May 2025 |
|---|
| Timothy C. Stonesifer | Director | 4.2K · < 1% | Open-market purchase, 3 Jun 2026 |
|---|
| Luciana Borio | Director | 3.1K · < 1% | Open-market sale, 3 Jun 2026 |
|---|
| Wayne A. I. Frederick | Director | 1.2K · < 1% | Grant or award, 20 May 2026 |
|---|
| Flavia H. Pease | EVP & CFO | 543 · < 1% | Shares withheld for tax, 1 Oct 2026 |
|---|
| Robert L. Huffines | Director | 106 · < 1% | Grant or award, 30 Sep 2026 |
|---|
| MAZELSKY JONATHAN JAY | Director | — | Grant or award, 30 Sep 2026 |
|---|
| Davis Lisa Blair | SVP, Chief HR Officer | — | Shares withheld for tax, 1 Aug 2026 |
|---|
| Panos Michael | EVP and CCO | — | Grant or award, 1 Apr 2026 |
|---|
| Cousin Laetitia | SVP, Reg, Quality & Compliance | — | Shares withheld for tax, 27 Feb 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
PODD in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.